Candel Therapeutics Inc Earnings

The next earnings date for Candel Therapeutics Inc is May 7, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Candel Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
05/07/2026	$-0.21

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Candel Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/26/2026	---	$-0.29	-17.01%
11/06/2025	---	$0	100.00%
08/14/2025	---	$-0.09	43.75%
05/13/2025	---	$-0.14	42.92%
11/14/2024	---	$-0.33	---
08/13/2024	---	$-0.74	---
05/14/2024	Before Market	$-0.28	---
03/28/2024	Before Market	$-0.38	-137.50%
11/09/2023	Before Market	$-0.31	-63.16%
08/10/2023	Before Market	$-0.34	-13.33%
05/11/2023	Before Market	$-0.30	14.29%
03/30/2023	Before Market	$-0.18	41.94%
11/10/2022	Before Market	$-0.30	14.29%
08/05/2022	Before Market	$-0.32	21.95%
05/12/2022	Before Market	$-0.32	-3.23%
03/29/2022	Before Market	$0.31	196.88%
11/12/2021	Before Market	$-0.26	10.34%
09/08/2021	Before Market	$-0.31	-158.33%
06/02/2021	---	$-0.35	---

More About Candel Therapeutics Inc

Website

https://www.candeltx.com

Country

USA

Full Time Employees

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

“Candel Therapeutics Inc Earnings” Can Refer to the Candel Therapeutics Inc Earnings Date

Some people say “Candel Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Candel Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Candel Therapeutics Inc Stock on the Earnings Date

If you own Candel Therapeutics Inc stock (CADL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Candel Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Candel Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Candel Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Candel Therapeutics Inc earnings or anything else related to the stock market.